AI Cardiac Event Forecasting for Asymptomatic Risk Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods fail to accurately predict sudden cardiovascular events in asymptomatic individuals within a near-term timeframe, relying instead on long-term risk estimators that are not individual-specific.

Innovation Solution

A large language model is trained using a unique dataset of medical data from asymptomatic individuals who experienced sudden cardiac death, incorporating coronary artery calcium scans, coronary CT angiographies, chest CTs, and blood samples, to predict near-term cardiovascular events through an AI-enabled system.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If a 10-year risk estimator based on CVD risk factors is used, then population-based epidemiological prediction is provided, but individual-level prediction accuracy is insufficient

Engineering Contradiction:
Improveprediction accuracyVSAvoidtimeframe
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The system changes the prediction timeframe parameter from long-term (10 years) to near-term (months to a year), and transforms the prediction approach from population-based epidemiological estimation to individual-level AI/ML prediction using multiple data types including imaging, blood markers, and clinical data

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The system adds multiple dimensions of data collection and analysis including coronary artery calcium scans, coronary CT angiography, chest CT, blood markers, and electrocardiograms, transitioning from single-parameter risk factor assessment to multi-dimensional comprehensive evaluation

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Reliability

If current risk assessment tools are used, then general cardiovascular risk estimation is provided, but sudden cardiac death prediction in asymptomatic individuals is not possible

Engineering Contradiction:
Improveprediction reliabilityVSAvoidindividual specificity
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The system applies local quality by customizing the prediction model for specific high-risk populations (asymptomatic individuals with abnormal findings on imaging or blood tests) rather than providing generic population risk assessment, enabling tailored prediction for those most susceptible to sudden cardiac death

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The system performs preliminary identification of high-risk individuals through screening for abnormal coronary artery calcium scores, coronary CT angiography findings, blood markers, or electrocardiogram abnormalities before the actual cardiac event occurs, allowing for early intervention

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS20250339104A1Artificial intelligence system for forecasting near-term sudden cardiac death and adverse cardiovascular events
Publication Date: 2025.11.06 HEART LUNG CORP
  • US20250339104A1 patent drawing

AI summary

According to an aspect of the present invention, there is provided computer-implemented method for forecasting near-term sudden cardiovascular events, comprising: pretraining a large language model transformer architecture using a processor with an associated computer memory device to recognize text associated with sudden cardiovascular events cases reporting sudden cardiovascular events following a medical exam appointment; obtaining relevant data regarding an asymptomatic individual comprising one or more of a coronary artery calcium (CAC) scan, a coronary CT angiography (CCTA), chest CT, blood markers, and electrocardiogram; providing the relevant data of the asymptomatic individual to the trained computer-implemented artificial neural network; receiving a forecast of the chance of near-term sudden cardiovascular events in the asymptomatic individual; and recommending the next diagnostic or therapeutic step for the asymptomatic individual.